Global Enteric Softgel Capsules Market-Industry Analysis and Forecast (2019-2026)


Global Enteric Softgel Capsules Market was valued US$ 2.93 Bn in 2018 and is expected to reach US$ 2.73 Bn by 2026 at a CAGR of 4.5% during the forecast period.

The global enteric softgel capsules market is expected to grow at a significant rate during the forecast period, because of growth in several R&D activities to increase the bioavailability of the drug, surge in demand for softgel health supplements, rise in consumer awareness related to preventative healthcare, and proliferation of distribution channels. Further, improvement in lifestyle pattern, rise in geriatric population, and an increase in the number of self-directed consumers have fuelled the market growth. However, stability concern with some water-soluble compounds and high cost associated with softgel can impede the market growth.

The health supplements segment dominates the market presently and is likely to retain its leading position during the forecast period due to the factors, such as, increase in adoption of softgel capsules, rise in awareness of nutraceutical supplements, for example, omega-3 and other vitamins, growth in geriatric population, and surge in demand for softgel-based health supplements in developing regions. In terms of sales channel, the global enteric softgel capsules market is can be bifurcated segmentd by into hospital pharmacies, retail pharmacies, supermarket stores, and online pharmacies. Among these, hospital pharmacies are expected to dominate the global enteric softgel capsules market because of the increased preference of patients to buy medicines from such pharmacies. The online pharmacy segment is projected to witness rapid growth during the forecast period due to raising awareness of online pharmacies, boosted by increased promotional activities by online service providers and rising competition that leads them to offer medicines at competitive prices to consumers.

North America is the leading market for enteric softgel capsules, in terms of revenue, followed by Europe. The U.S. holds the largest share of the enteric softgel capsules market in North America owing to high per capita health care expenditure, significant investment in R&D for effective treatment alternatives, and a rise in awareness and adoption of health and nutraceutical supplements encapsulated in

Leave a Reply

Your email address will not be published. Required fields are marked *